{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:20:07Z","timestamp":1764260407661,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201550"],"award-info":[{"award-number":["82201550"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10067-024-07240-8","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T01:29:30Z","timestamp":1732066170000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological and imaging differences between pediatric and adult patients with anti-hydroxy-3-methyl-glutaryl-coenzyme A reductase necrotizing myopathy"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6315-7587","authenticated-orcid":false,"given":"MengTing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiKang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YaWen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JingChu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiMing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HongJun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhaoXia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3282-9123","authenticated-orcid":false,"given":"Yun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"2","key":"7240_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-180308","volume":"5","author":"J Schmidt","year":"2018","unstructured":"Schmidt J (2018) Current classification and management of inflammatory myopathies. J Neuromuscul Dis 5(2):109\u2013129","journal-title":"J Neuromuscul Dis"},{"issue":"12","key":"7240_CR2","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F et al (2018) Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75(12):1528\u20131537","journal-title":"JAMA Neurol"},{"issue":"1","key":"7240_CR3","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1212\/NXI.0000000000000513","volume":"6","author":"J Lim","year":"2019","unstructured":"Lim J, Rietveld A, De Bleecker JL, Badrising UA, Saris CGJ, van der Kooi AJ et al (2019) Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy. Neurol Neuroimmunol Neuroinflamm 6(1):e513","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"7240_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W (2018) 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord 28(1):87\u201399","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"7240_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.semarthrit.2020.02.009","volume":"50","author":"O Landon-Cardinal","year":"2020","unstructured":"Landon-Cardinal O, Koumako C, Hardouin G, Granger B, Reyngoudt H, Boisserie JM et al (2020) Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI. Semin Arthritis Rheum 50(6):1437\u20131440","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"7240_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3988\/jcn.2022.0374","volume":"19","author":"EK Oh","year":"2023","unstructured":"Oh EK, Lee SA, Lee HJ, Cha YJ, Kim S, Lee HS et al (2023) Clinical and radiological features of Korean patients with anti-HMGCR myopathy. J Clin Neurol (Seoul, Korea) 19(5):460\u2013468","journal-title":"J Clin Neurol (Seoul, Korea)"},{"issue":"4","key":"7240_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J et al (2017) Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis 76(4):681\u2013687","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7240_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00415-022-11447-7","volume":"270","author":"L Fionda","year":"2023","unstructured":"Fionda L, Lauletta A, Leonardi L, Perez JA, Morino S, Merlonghi G et al (2023) Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies. J Neurol 270(2):960\u2013974","journal-title":"J Neurol"},{"issue":"2","key":"7240_CR9","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.autrev.2021.102993","volume":"21","author":"G Merlonghi","year":"2022","unstructured":"Merlonghi G, Antonini G, Garibaldi M (2022) Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge. Autoimmun Rev 21(2):102993","journal-title":"Autoimmun Rev"},{"issue":"2","key":"7240_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","volume":"56","author":"WC Liang","year":"2017","unstructured":"Liang WC, Uruha A, Suzuki S, Murakami N, Takeshita E, Chen WZ et al (2017) Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies. Rheumatology (Oxford) 56(2):287\u2013293","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"7240_CR11","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s10072-020-04491-6","volume":"41","author":"D Velardo","year":"2020","unstructured":"Velardo D, Faravelli I, Cinnante C, Moggio M, Comi GP (2020) Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature review. Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 41(10):3009\u20133013","journal-title":"Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"4","key":"7240_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.160871","volume":"44","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Betteridge ZE, Simou S, Jacques TS, Pilkington C, Wood M et al (2017) Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients. J Rheumatol 44(4):488\u2013492","journal-title":"J Rheumatol"},{"issue":"2","key":"7240_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JND-221557","volume":"10","author":"S Sener","year":"2023","unstructured":"Sener S, Batu ED, Sari S, Kasap Cuceoglu M, Yildiz AE, Talim B et al (2023) A child with refractory and relapsing anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase myopathy: case-based review. J Neuromuscul Dis 10(2):279\u2013291","journal-title":"J Neuromuscul Dis"},{"key":"7240_CR14","doi-asserted-by":"publisher","first-page":"1102539","DOI":"10.3389\/fped.2023.1102539","volume":"11","author":"K Watanuki","year":"2023","unstructured":"Watanuki K, Koga H (2023) Case report: diagnostic clues for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy in pediatric patients. Front Pediatr 11:1102539","journal-title":"Front Pediatr"},{"key":"7240_CR15","doi-asserted-by":"publisher","first-page":"1123380","DOI":"10.3389\/fneur.2023.1123380","volume":"14","author":"CH Wang","year":"2023","unstructured":"Wang CH, Liang WC (2023) Pediatric immune-mediated necrotizing myopathy. Front Neurol 14:1123380","journal-title":"Front Neurol"},{"issue":"12","key":"7240_CR16","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7240_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nmd.2013.05.001","volume":"23","author":"JM Morrow","year":"2013","unstructured":"Morrow JM, Matthews E, Raja Rayan DL, Fischmann A, Sinclair CD, Reilly MM et al (2013) Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul Disord 23(8):637\u2013646","journal-title":"Neuromuscul Disord"},{"issue":"7\u20138","key":"7240_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0960-8966(03)00091-9","volume":"13","author":"E Mercuri","year":"2003","unstructured":"Mercuri E, Cini C, Pichiecchio A, Allsop J, Counsell S, Zolkipli Z et al (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 13(7\u20138):554\u2013558","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"7240_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00415-005-0684-4","volume":"252","author":"D Fischer","year":"2005","unstructured":"Fischer D, Walter MC, Kesper K, Petersen JA, Aurino S, Nigro V et al (2005) Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 252(5):538\u2013547","journal-title":"J Neurol"},{"issue":"4","key":"7240_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41379-018-0164-x","volume":"32","author":"C Cai","year":"2019","unstructured":"Cai C, Anthony DC, Pytel P (2019) A pattern-based approach to the interpretation of skeletal muscle biopsies. Mod Pathol: An Off J U S Can Acad Pathol Inc 32(4):462\u201383","journal-title":"Mod Pathol: An Off J U S Can Acad Pathol Inc"},{"issue":"21","key":"7240_CR21","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.3390\/jcm11216566","volume":"11","author":"M Yang","year":"2022","unstructured":"Yang M, Ji S, Xu L, Zhang Q, Li Y, Gao H et al (2022)\u00a0The clinicopathological distinction between immune-mediated necrotizing myopathy and limb-girdle muscular dystrophy R2: key points to prevent misdiagnosis. J Clin Med 11(21):6566","journal-title":"J Clin Med."},{"issue":"3","key":"7240_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18(3):91\u201393","journal-title":"Turk J Emerg Med"},{"issue":"1","key":"7240_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00415-021-10621-7","volume":"269","author":"Y Hou","year":"2022","unstructured":"Hou Y, Shao K, Yan Y, Dai T, Li W, Zhao Y et al (2022) Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy. J Neurol 269(1):280\u2013293","journal-title":"J Neurol"},{"issue":"10","key":"7240_CR24","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K et al (2016) Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 87(10):1038\u20131044","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"7240_CR25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00296-021-05063-3","volume":"42","author":"L Gupta","year":"2022","unstructured":"Gupta L, Nune A, Naveen R, Verma R, Prasad P, Kharbanda R et al (2022) The prevalence and clinical characteristics of anti-HMGCR (anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) antibodies in idiopathic inflammatory myopathy: an analysis from the MyoCite registry. Rheumatol Int 42(7):1143\u20131154","journal-title":"Rheumatol Int"},{"key":"7240_CR26","doi-asserted-by":"publisher","first-page":"866701","DOI":"10.3389\/fimmu.2022.866701","volume":"13","author":"P Szczesny","year":"2022","unstructured":"Szczesny P, Barsotti S, Nennesmo I, Danielsson O, Dastmalchi M (2022) Screening for anti-HMGCR antibodies in a large single myositis center reveals infrequent exposure to statins and diversiform presentation of the disease. Front Immunol 13:866701","journal-title":"Front Immunol"},{"issue":"5","key":"7240_CR27","first-page":"787","volume":"56","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, Pinal-Fernandez I, Lloyd TE, Albayda J, Paik J, Werner JL et al (2017) More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford) 56(5):787\u2013794","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"7240_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"93","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB et al (2014) Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 93(3):150\u2013157","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"7240_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL et al (2017) Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res (Hoboken) 69(7):1088\u20131094","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"47","key":"7240_CR30","doi-asserted-by":"publisher","first-page":"e13236","DOI":"10.1097\/MD.0000000000013236","volume":"97","author":"L Huang","year":"2018","unstructured":"Huang L, Wang L, Yang Y, Chen H, Liu Y, Liu K et al (2018) Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis. Medicine (Baltimore) 97(47):e13236","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"7240_CR31","first-page":"989","volume":"51","author":"HX Yang","year":"2019","unstructured":"Yang HX, Tian XL, Jiang W, Li WL, Liu QY, Peng QL et al (2019) Clinical and pathological characteristics of immune mediated necrotizing myopathy. Beijing Da Xue Xue Bao Yi Xue Ban 51(6):989\u2013995","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"issue":"3","key":"7240_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63(3):713\u2013721","journal-title":"Arthritis Rheum"},{"issue":"5","key":"7240_CR33","doi-asserted-by":"publisher","first-page":"e248880","DOI":"10.1136\/bcr-2022-248880","volume":"15","author":"B Adler","year":"2022","unstructured":"Adler B, Christopher-Stine L, Tiniakou E (2022) Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy. BMJ Case Rep 15(5):e248880","journal-title":"BMJ Case Rep"},{"issue":"1","key":"7240_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12969-022-00699-2","volume":"20","author":"A Mekmangkonthong","year":"2022","unstructured":"Mekmangkonthong A, Amornvit J, Numkarunarunrote N, Veeravigrom M, Khaosut P (2022) Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review. Pediatr Rheumatol Online J 20(1):40","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"7240_CR35","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1002\/mus.26729","volume":"61","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Kondo Y, Kanazawa N, Kaneko A, Tominaga N, Nagai M et al (2020) Anti-HMGCR myopathy following acute Epstein-Barr virus infection. Muscle Nerve 61(1):E5-e8","journal-title":"Muscle Nerve"},{"issue":"5","key":"7240_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s10072-021-05146-w","volume":"42","author":"A Barp","year":"2021","unstructured":"Barp A, Velardo D, Ciscato P, Sansone VA, Lunetta C (2021) Anti-HMGCR myopathy misdiagnosed as motor neuron disease and complicated with COVID-19 infection. Neurol Sci 42(5):1679\u20131682","journal-title":"Neurol Sci"},{"issue":"8","key":"7240_CR37","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/acr.21671","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS et al (2012) Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res (Hoboken) 64(8):1233\u20131237","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"7240_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/tan.14950","volume":"101","author":"Y Ohnuki","year":"2023","unstructured":"Ohnuki Y, Suzuki S, Uruha A, Oyama M, Suzuki S, Kulski JK et al (2023) Association of immune-mediated necrotizing myopathy with HLA polymorphisms. Hla 101(5):449\u2013457","journal-title":"Hla"},{"issue":"1","key":"7240_CR39","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","volume":"6","author":"P Mohassel","year":"2019","unstructured":"Mohassel P, Landon-Cardinal O, Foley AR, Donkervoort S, Pak KS, Wahl C et al (2019) Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. Neurol Neuroimmunol Neuroinflamm 6(1):e523","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7240_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jocn.2018.08.010","volume":"57","author":"Y Jiao","year":"2018","unstructured":"Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J et al (2018) Statin-na\u00efve anti-HMGCR antibody-mediated necrotizing myopathy in China. J Clin Neurosci: Off J Neurosurg Soc Australas 57:13\u201319","journal-title":"J Clin Neurosci: Off J Neurosurg Soc Australas"},{"issue":"10","key":"7240_CR41","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1111\/imj.16004","volume":"53","author":"E Tan","year":"2023","unstructured":"Tan E, Knight J, Khonasti S, Nolan D, McGettigan B, Bundell C et al (2023) Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy. Intern Med J 53(10):1846\u20131853","journal-title":"Intern Med J"},{"issue":"1","key":"7240_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s40001-023-01363-5","volume":"28","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhao Y, Hao H, Wang Z, Gao F, Zhang W et al (2023) What should we expect when two myositis-specific antibodies coexist in a patient. Eur J Med Res 28(1):429","journal-title":"Eur J Med Res"},{"issue":"23","key":"7240_CR43","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.3390\/jcm11236972","volume":"11","author":"HL Huang","year":"2022","unstructured":"Huang HL, Lin WC, Tsai WL, Weng CT, Weng MY, Wu CH et al (2022) Coexistence of multiple myositis-specific antibodies in patients with idiopathic inflammatory myopathies. J Clin Med 11(23):6972","journal-title":"J Clin Med"},{"issue":"4","key":"7240_CR44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mus.27382","volume":"64","author":"KH Lee","year":"2021","unstructured":"Lee KH, Gao Y, Lau V (2021) Statin-associated anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) myopathy: imaging findings on thigh-muscle magnetic resonance imaging (MRI) in six patients. Muscle Nerve 64(4):500\u2013504","journal-title":"Muscle Nerve"},{"issue":"1","key":"7240_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/rheumatology\/keac269","volume":"62","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zheng Y, Wang Y, Xiong H, Que C, Zhang X et al (2022) Thigh MRI in antisynthetase syndrome, and comparisons with dermatomyositis and immune-mediated necrotizing myopathy. Rheumatology (Oxford) 62(1):310\u2013320","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7240_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nmd.2020.03.008","volume":"30","author":"B Su\u00e1rez","year":"2020","unstructured":"Su\u00e1rez B, Jofr\u00e9 J, Lozano-Arango A, Ortega X, Diaz J, Calcagno G et al (2020) Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy. Neuromuscul Disord: NMD 30(6):503\u2013509","journal-title":"Neuromuscul Disord: NMD"},{"issue":"6","key":"7240_CR47","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/mus.25567","volume":"56","author":"P Mohassel","year":"2017","unstructured":"Mohassel P, Foley AR, Donkervoort S, Fequiere PR, Pak K, B\u00f6nnemann CG et al (2017) Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child. Muscle Nerve 56(6):1177\u20131181","journal-title":"Muscle Nerve"},{"issue":"3","key":"7240_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","volume":"30","author":"J Day","year":"2020","unstructured":"Day J, Otto S, Cash K, Limaye V (2020) Clinical and histological features of immune-mediated necrotising myopathy: a multi-centre South Australian cohort study. Neuromuscul Disord 30(3):186\u2013199","journal-title":"Neuromuscul Disord"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07240-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:53:04Z","timestamp":1736776384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07240-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7240"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07240-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"30 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}